HPV Message Testing and Social Media Campaign
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03747302|
Recruitment Status : Enrolling by invitation
First Posted : November 20, 2018
Last Update Posted : August 14, 2019
|Condition or disease||Intervention/treatment||Phase|
|Vaccine Human Papilloma Virus||Other: Social Media Message about HPV and HPV vaccine Other: Social media message about risk of electronic cigarettes.||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||1200 participants|
|Intervention Model:||Parallel Assignment|
|Masking Description:||Participants are not aware of which arm of social messaging they are receiving and whether they are receiving the control message or not|
|Primary Purpose:||Health Services Research|
|Official Title:||HPV Message Testing and Social Media Campaign|
|Actual Study Start Date :||December 12, 2018|
|Estimated Primary Completion Date :||December 2019|
|Estimated Study Completion Date :||December 2019|
Experimental: HPV Messaging
Subjects are randomized to receive one of five messages on one of the four themes about HPV vaccination.
Other: Social Media Message about HPV and HPV vaccine
Messages educate parents with facts about HPV vaccination.
Subjects are randomized to receive one of five messages about electronic cigarettes.
Other: Social media message about risk of electronic cigarettes.
Messages educate parents with facts about electronic cigarettes. This is an attention control group without outcomes obtained.
- Changes in intention to vaccinate their child with HPV vaccine [ Time Frame: pre test immediately before viewing message and post test immediately after viewing message. Approximately one hour. ]Pre and Post surveys of participants viewing a specific social message
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03747302
|United States, New Hampshire|
|Dartmouth-Hitchcock Medical Center|
|Lebanon, New Hampshire, United States, 03756|
|Principal Investigator:||Ardis L Olson, MD||Trustees of Dartmouth College|
|Principal Investigator:||Sun Jung Kim, PhD||Massey Cancer Center|